Showing results (1741-1750 of 2,027) with videos related to

Sort By:
Pageof 203
Molecular Cancer Therapeutics|October 5, 2007
Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of miceWenjuan Wu, Michael S O'Reilly, Robert R Langley, et al.
Medical Care|January 26, 2012
Prioritization in comparative effectiveness research: the CANCERGEN ExperienceRahber Thariani, William Wong, Josh J Carlson, et al.
The American Surgeon|December 31, 2020
Pure and Hybrid Deep Learning Models can Predict Pathologic Tumor Response to Neoadjuvant Therapy in Pancreatic Adenocarcinoma: A Pilot StudyMichael D Watson, Maria R Baimas-George, Keith J Murphy, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2012
Harnessing nanoparticles to improve toxicity after head and neck radiationRafael A Madero-Visbal, Beatrice E Alvarado, Jimmie F Colon, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and functionCatherine A Spilling, Mohani-Preet K Bajaj, Daniel R Burrage, et al.
Alcohol, Clinical & Experimental Research|December 5, 2023
Differential genetic associations between dimensions of eating disorders and alcohol involvement in late adolescent twinsBaiyu Qi, Laura M Thornton, Courtney E Breiner, et al.
Investigational New Drugs|October 24, 2009
Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic miceJimmie Colon, Md Riyaz Basha, Rafael Madero-Visbal, et al.
The American Surgeon|December 21, 2020
Effect of Margin Status on Survival After Resection of Hilar Cholangiocarcinoma in the Modern Era of Adjuvant TherapiesMichael D Watson, Maria R Baimas-George, Michael J Passeri, et al.
Acta Leidensia|January 1, 1990
Large scale ivermectin distribution and its epidemiological consequencesJ Remme, G De Sole, K Y Dadzie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcomaFrancis P Worden, Jeremy M G Taylor, Janet S Biermann, et al.
Pageof 203